186 related articles for article (PubMed ID: 19270654)
1. C-Path sets diagnostics standard.
Roberts J
Nat Biotechnol; 2009 Mar; 27(3):213. PubMed ID: 19270654
[No Abstract] [Full Text] [Related]
2. Finding control in quality control of unit-use prothrombin time tests.
Pontius CA
MLO Med Lab Obs; 2001 May; 33(5):38-40, 42. PubMed ID: 11373813
[No Abstract] [Full Text] [Related]
3. FDA and CLIA oversight of advanced diagnostics and biomarker tests.
Terry SF
Genet Test Mol Biomarkers; 2010 Jun; 14(3):285-7. PubMed ID: 20578940
[No Abstract] [Full Text] [Related]
4. Modification of In Vitro Diagnostic Devices: Leveling the Playing Field.
Rychert J; Delgado JC; Genzen JR
Clin Chem; 2020 Jun; 66(6):760-762. PubMed ID: 32278318
[No Abstract] [Full Text] [Related]
5. Better laboratory evaluations of instruments and kits are required.
Fraser CG; Singer R
Clin Chem; 1985 May; 31(5):667-70. PubMed ID: 3986994
[TBL] [Abstract][Full Text] [Related]
6. The complexity of compliance in IVD manufacturing.
Lokas K
Med Device Technol; 2005 Dec; 16(10):26-7. PubMed ID: 16419923
[TBL] [Abstract][Full Text] [Related]
7. Urinary protein measurement in 2018: don't make this practice banal.
Cristol JP;
Ann Biol Clin (Paris); 2018 Dec; 76(6):607-608. PubMed ID: 30543183
[No Abstract] [Full Text] [Related]
8. Total error evaluation of Roche direct HDL-cholesterol reagent and calibrator across 31 lot combinations: a 2-year experience.
Cobbaert CM; Luderer TK
Clin Chem; 2000 Jan; 46(1):133-4. PubMed ID: 10620588
[No Abstract] [Full Text] [Related]
9. New HDL-cholesterol reagent formulation reduces interference from samples with abnormal proteins.
Hoefner DM
Clin Chim Acta; 2006 Dec; 374(1-2):142-4. PubMed ID: 16701600
[No Abstract] [Full Text] [Related]
10. Combination of three rapid tests: An alternative approach to confirmatory laboratory diagnosis of HIV infection in Bangladesh.
Munshi SU; Ahmed J; Ahmed M; Nessa A; Tabassum S
Indian J Med Microbiol; 2009; 27(2):170-1. PubMed ID: 19384049
[No Abstract] [Full Text] [Related]
11. [Coordination of patient care teams and industries associated with the field of the clinical pathology: contribution of the maker and developer of diagnostic reagent kits to patient care teams].
Minote S
Rinsho Byori; 2009 Aug; Suppl 144():241-4. PubMed ID: 22685827
[No Abstract] [Full Text] [Related]
12. Patient-initiated laboratory testing: applauding the inevitable.
Soloway HB
JAMA; 1990 Oct; 264(13):1718. PubMed ID: 2398612
[No Abstract] [Full Text] [Related]
13. Tests for vaccine efficacy.
John TJ
Indian Pediatr; 1998 Mar; 35(3):284-5. PubMed ID: 9707889
[No Abstract] [Full Text] [Related]
14. Behringwerke anti-HIV test kits.
Becker W
Lancet; 1989 Aug; 2(8660):458-9. PubMed ID: 2569647
[No Abstract] [Full Text] [Related]
15. [Development of measurement methods and contributions to medical care in the clinical laboratory].
Sugiuchi H
Rinsho Byori; 2008 Jan; 56(1):66-71. PubMed ID: 18318234
[TBL] [Abstract][Full Text] [Related]
16. Guide to the expression of uncertainty of measurement: point/counterpoint.
Lequin RM
Clin Chem; 2004 May; 50(5):977-8. PubMed ID: 15105367
[No Abstract] [Full Text] [Related]
17. In-process testing and limits.
Sjöholm I
Dev Biol Stand; 1997; 91():73-8. PubMed ID: 9413685
[No Abstract] [Full Text] [Related]
18. [External evaluation of quality of cytological studies in laboratories in Russia].
Shabalova IP
Klin Lab Diagn; 2002 Apr; (4):51-3. PubMed ID: 12412511
[No Abstract] [Full Text] [Related]
19. Development of novel IVD assays: a manufacturer's perspective.
Metcalfe TA
Scand J Clin Lab Invest Suppl; 2010; 242():23-6. PubMed ID: 20515272
[TBL] [Abstract][Full Text] [Related]
20. "Research use only" reagents: is there an imperative for increased FDA oversight?
O'Leary TJ
Clin Chem; 2011 Dec; 57(12):1681-3. PubMed ID: 21998341
[No Abstract] [Full Text] [Related]
[Next] [New Search]
